BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7537837)

  • 1. Peptide-based tachykinin NK2 receptor antagonists.
    Quartara L; Rovero P; Maggi CA
    Med Res Rev; 1995 Mar; 15(2):139-55. PubMed ID: 7537837
    [No Abstract]   [Full Text] [Related]  

  • 2. Tachykinin receptors mediate atropine-resistant rat duodenal reflex contractions in vivo.
    Giuliani S; Tramontana M; Lecci A; Maggi CA
    Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):327-35. PubMed ID: 8878063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of scyliorhinin I and synthetic scyliorhinin I derivatives at mammalian tachykinin NK1, NK2 and NK3 receptors.
    Patacchini R; Quartara L; Rolka K; Zboinska J; Kupryszewski G; Maggi CA
    Eur J Pharmacol; 1993 Dec; 250(2):311-6. PubMed ID: 7509285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea-pigs in vivo.
    Hirayama Y; Lei YH; Barnes PJ; Rogers DF
    Br J Pharmacol; 1993 Mar; 108(3):844-51. PubMed ID: 7682142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
    Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
    Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins.
    Maggi CA; Patacchini R; Eglezos A; Quartara L; Giuliani S; Giachetti A
    Br J Pharmacol; 1992 Sep; 107(1):27-33. PubMed ID: 1384907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
    Picard P; Regoli D; Couture R
    Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
    Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
    Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of tachykinin NK1 receptors in plasma protein extravasation induced by tachykinins in the guinea pig upper airways.
    Evangelista S; Paoli S; Giachetti A; Manzini S
    Neuropeptides; 1997 Feb; 31(1):65-70. PubMed ID: 9574840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo characterization of tachykinin receptors responsible for the central cardiovascular effects of substance P and neurokinin A.
    Culman J; Tschöpe C; Picard P; Prat A; Regoli D; Couture R; Unger T
    Regul Pept; 1993 Jul; 46(1-2):364-6. PubMed ID: 7692538
    [No Abstract]   [Full Text] [Related]  

  • 11. Tachykinin NK2 receptors in the hamster urinary bladder: in vitro and in vivo characterization.
    Tramontana M; Patacchini R; Lecci A; Giuliani S; Maggi CA
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):293-300. PubMed ID: 9774215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tachykinin effects on bladder activity in conscious normal rats.
    Ishizuka O; Mattiasson A; Andersson KE
    J Urol; 1995 Jul; 154(1):257-61. PubMed ID: 7539864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological evidence for neurokinin receptors in murine neuroblastoma C1300 cells.
    Fukuhara S; Mukai H; Munekata E
    Peptides; 1995; 16(2):211-4. PubMed ID: 7540290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of tachykinin receptors on neurones in the ventral tegmental area of rat brain slices.
    Seabrook GR; Bowery BJ; Hill RG
    Eur J Pharmacol; 1995 Jan; 273(1-2):113-9. PubMed ID: 7537676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological analysis of receptors involved in tachykininergic contraction induced by electrical transmural stimulation in the rabbit iris sphincter muscle.
    Kunitomo M; Imaizumi N; Sameshima E; Fujiwara M
    Regul Pept; 1993 Jul; 46(1-2):282-4. PubMed ID: 7692516
    [No Abstract]   [Full Text] [Related]  

  • 16. Tachykinin receptors mediating contraction of guinea pig lung strips.
    Killingsworth CR; Shore SA
    Regul Pept; 1995 May; 57(2):149-61. PubMed ID: 7544902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of YM-44781, YM-44778 and YM-49598, novel tachykinin antagonists, in a drug-induced bladder contraction model.
    Choppin A; Groke G; Bringas A; Stepan G; Dillon MP
    Pharmacology; 2002 May; 65(2):96-102. PubMed ID: 11937780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potencies of agonists acting at tachykinin receptors in the oestrogen-primed rat uterus: effects of peptidase inhibitors.
    Fisher L; Pennefather JN
    Eur J Pharmacol; 1997 Sep; 335(2-3):221-6. PubMed ID: 9369377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitation and contraction in the circular muscle of guinea-pig duodenum.
    Zagorodnyuk V; Santicioli P; Maggi CA; Giachetti A
    Br J Pharmacol; 1995 May; 115(2):237-46. PubMed ID: 7545517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
    Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
    Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.